AI in Healthcare – Precision Medicine and Diagnosis

By knowing the early risk factors prediction of disease through precision medicine has enhanced medical care surpassed the conventional symptom-driven treatment approach. To choose the best course for precision medicine, it is requisite to carefully consider both broad and overall patient data, the required posology data of patient; in case to understand the patient history to differentiate between sick and reasonably healthy individuals. This will enhance our comprehension of the molecular markers that can signify alterations in health. Artificial intelligence, precision, and genetic medicine leads to the better patient care. Genomic medicine technologies are being used by patients who have distinct healthcare needs or less typical therapeutic responses. Through sophisticated computing and inference, artificial intelligence (AI) offers insights that improve medical decision-making by allowing the system to think and learn. This in-depth study examines the relationship between artificial intelligence (AI) and healthcare, with a particular emphasis on the revolutionary potential of AI-driven personalized treatment regimens in the field of precision medicine. The essay emphasizes its significant influence on healthcare across multiple sectors and places a focus on responsible growth for the common good. In order to ensure a full investigation of the topic, the research method entails a detailed examination of AI in healthcare through indexed databases. The story explores how AI is transforming treatment planning, diagnosis, and patient care, especially in fields like radiation. When treating patients with metastatic cutaneous melanoma, standard medical imaging methods including CT, MRI, and PET are essential. Through the improvement of customized image-guided precision medicine strategies, advances in artificial intelligence (AI) techniques like radiomics, machine learning, and deep learning have the potential to completely transform the use of medical imaging. In this article, we will analyze how AI/radiomics might be used to mine data from medical pictures, including tumor volume, heterogeneity, and shape, to give doctors insights into cancer biology and enhance patient care in the clinic and during clinical trials. Artificial intelligence (AI) holds promise for improving many aspects of treating metastatic cutaneous melanoma, such as diagnosis, planning, delivery, response assessment, toxicity assessment, and patient monitoring.